Nasdaq Moves to Delist PomDoctor After Compliance Lapse
POM sits 41% above its 52-week low of $0.5.
Summary
Nasdaq will suspend trading in PomDoctor securities following non-compliance, moving to delist the company after a compliance lapse. PomDoctor had received a Nasdaq Staff Delisting Determination, a formal step toward removal from the exchange. This followed a July 13 filing in which the company said it had regained compliance after its ADS price held above $1.00 for 10 consecutive days. The new determination suggests the company has again fallen out of compliance, likely on the minimum bid price requirement. Shareholders approved a 10-to-1 reverse split on September 30, but the delisting notice indicates that action has not yet resolved the issue. The company also faces a going concern warning and a RMB238.2 million H1 2026 net loss, adding pressure to its listing status.
Updates
· SEC 6-K — PomDoctor received the Nasdaq delisting determination on October 6, 2026, after its ADSs closed below $1.00 for 30 consecutive business days from August 24 to October 5, 2026; it plans to request a hearing by October 13, 2026.
- Delisting Determination — PomDoctor received a delisting determination from The Nasdaq Global Market for non-compliance with the Minimum Bid Price Requirement. Unless it requests a hearing, its securities will be suspended on October 15, 2026; a timely request stays suspension.
- Reverse Split — The Company effected a 1-for-18 reverse stock split on June 22, 2026, making it ineligible for a compliance period under Nasdaq Listing Rule 5810(c)(3)(A)(iv).
- Hearing Plan — The Company intends to present its plan to regain compliance with the Minimum Bid Price Requirement at the Nasdaq Hearings Panel hearing.
All 8 details
- Pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iv), a company is not eligible for a compliance period if it has effected a reverse stock split during the prior one-year period.
- Unless the Company timely requests a hearing before a Nasdaq Hearings Panel, the Company's securities will be suspended from trading at the opening of business on October 15, 2026.
- A timely hearing request will stay the suspension of the Company's securities and the filing of the Form 25-NSE pending the Panel's decision.
- The Company effected a 1-for-18 reverse stock split on June 22, 2026.
- The delisting is from The Nasdaq Global Market.
- Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), the Minimum Bid Price Requirement.
- Ordinarily, a 180-calendar-day compliance period is afforded for minimum bid price non-compliance, but Company is not eligible because it effected a 1-for-18 reverse stock split on June 22, 2026, within the prior one-year period.
- Company intends to present its plan to regain compliance with the Minimum Bid Price Requirement at the Nasdaq Hearings Panel hearing.
At the time of this announcement, POM was trading at $0.70 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.1M. The 52-week trading range was $0.50 to $115.74. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.